Analystreport

Corvus Pharmaceuticals Inc (NASDAQ: CRVS) had its price target lowered by analysts at Wedbush from $11.00 to $8.00. They now have an "outperform" rating on the stock.

Corvus Pharmaceuticals, Inc.  (CRVS) 
Last corvus pharmaceuticals, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corvuspharma.com